loader
Please Wait
Applying Filters...

Looking for Controlled & Modified Release? Find Controlled & Modified Release Agents used in Naproxen to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 37Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Evonik

02 5Gangwal Healthcare

03 5Nanjing Well Pharmaceutical

04 2Actylis

05 2Aeon Procare

06 3Alcedo Pharmachem

07 32BASF

08 4Finar

09 2Gangwal Chemicals

10 6Ideal Cures Pvt Ltd

11 14Kerry

12 1Kima Chemical

13 1Lonza Capsugel

14 2Nomisma Healthcare

15 1Sigachi Industries

16 2The Dow Chemical Company

17 3Vertellus

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Grade : Oral

Brand Name : EUDRAGIT® L 100

Excipient Details : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Brand : EUDRAGIT® L 100

Applications : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5

Grade : Oral

arrow

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Parenteral, Topical, Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Brand : EUDRAGIT® L 100-55

Applications : EUDRAGIT® L 100-55 polymer is used in delayed, sustained-release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 30 D-55

Grade : Oral

arrow

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : GELLETS-P®

Applications : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Grade : Oral

arrow

06

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

Brand : KOLLIDON SR

Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specs : Not Available

Grade : Not Available

arrow
blank

07

arrow
Boulder Peptide 2024
Not Confirmed

08

arrow
Boulder Peptide 2024
Not Confirmed

09

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed
blank

10

arrow
Boulder Peptide 2024
Not Confirmed

11

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : PLGA-PEG

Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow

Brand : PLGA-PEG

Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow
blank

12

arrow
Boulder Peptide 2024
Not Confirmed

14

arrow
Boulder Peptide 2024
Not Confirmed

15

arrow
Boulder Peptide 2024
Not Confirmed

17

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

Brand : ESPHERES EM

Applications : These spheres can be used as an inert base for modified release formulations promoting consistency and uniformity of release profile thus ensuring a uniform therapeutic response.

Pharmacopoeia Ref : Particle Sizes - #20 – #30, #30 – #40 and #40 – #60

Technical Specs : Not Available

Grade : Oral

arrow
blank

21

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

Brand : METHOCEL™

Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Not Available

arrow
blank

26

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed
blank

28

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

Brand : VCAPS® ENTERIC

Applications : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

Pharmacopoeia Ref : Complies with relevant European, Japanese and US Pharmacopeia monographs

Technical Specs : Water content – less than 6%; Size #0

Grade : Oral

arrow
blank

31

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed
blank

33

arrow
Boulder Peptide 2024
Not Confirmed

37

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

Brand : KOLLICOAT SR 30 D

Applications : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specs : Not Available

Grade : Not Available

arrow
blank

38

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

Brand : KOLLICOAT MAE 100-55

Applications : Enteric coating with release above pH 5.5 (non-neutralized powder), fast redispersing for aqueaous and organic coating

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Not Available

arrow
blank

39

arrow
Boulder Peptide 2024
Not Confirmed

40

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

Brand : KOLLICOAT MAE 30 DP

Applications : Enteric coating with release above pH 5.5 (30 % solids content dispersion)

Pharmacopoeia Ref : Ph. Eur.: Methacrylic Acid

Technical Specs : Not Available

Grade : Not Available

arrow
blank

43

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

Brand Name : Soluplus

Excipient Details : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Pharmacopoeia Ref : Polyvinyl caprolactam – poly...

Technical Specs :

Grade :

arrow

Brand : SOLUPLUS

Applications : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Pharmacopoeia Ref : Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

Technical Specs : Not Available

Grade : Not Available

arrow
blank